Alvotech (ALVO) Interest Income - Net (2021 - 2026)
Alvotech's (ALVO) quarterly Interest Income - Net came in at -$37.1 million in Q2 2026, down 1057.57% on a YoY basis from $3.9 million in Q2 2025, and down 5.98% quarter-over-quarter from -$35.0 million in Q1 2026.
Analysis
Alvotech (ALVO) Interest Income - Net (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Interest Income - Net for 6 consecutive years, with -$37.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest Income - Net fell 1057.57% year-over-year to -$37.1 million; the trailing twelve-month figure through Jun 2026 stood at -$123.1 million (down 67.45% YoY), and the FY2025 full-year result was -$59.0 million, down 7.34% from the prior year.
- Interest Income - Net eased to -$37.1 million in Q2 2026 per ALVO's latest filing, from -$35.0 million in the prior quarter.
- Across five years, Interest Income - Net topped out at -$3.2 million in Q2 2025 and bottomed at -$57.3 million in Q4 2023.
- Historically, Interest Income - Net has averaged -$26.1 million across 5 years, with a median of -$31.3 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Interest Income - Net surged 91.24% in 2025, then slumped 1057.57% in 2026.
- Over 5 years, Interest Income - Net stood at -$35.4 million in 2022, then plunged by 61.86% to -$57.3 million in 2023, then grew by 4.07% to -$54.9 million in 2024, then jumped by 86.59% to -$7.4 million in 2025, then sank by 404.07% to -$37.1 million in 2026.
- According to Business Quant data, Interest Income - Net over the past three periods registered -$37.1 million, -$35.0 million, and -$7.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.91 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.15 Bn | 18.27 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.68 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 526.37 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | -37.14 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 408.32 Mn | 367.07 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 182.68 Mn | 182.68 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -37.14 Mn |
| Mar 31, 2026 | -35.04 Mn |
| Dec 31, 2025 | -7.37 Mn |
| Sep 30, 2025 | -43.54 Mn |
| Jun 30, 2025 | -3.21 Mn |
| Mar 31, 2025 | -4.83 Mn |
| Dec 31, 2024 | -54.92 Mn |
| Sep 30, 2024 | -10.55 Mn |
| Jun 30, 2024 | -36.63 Mn |
| Mar 31, 2024 | -4.40 Mn |
| Dec 31, 2023 | -57.25 Mn |
| Jun 30, 2023 | -27.58 Mn |
| Dec 31, 2022 | -35.37 Mn |
| Jun 30, 2022 | -7.60 Mn |
| Dec 31, 2021 | -4.84 Mn |
| Sep 30, 2021 | -1.60 Mn |